Criminal Justice

HB 2154 establishes Pennsylvania's Prison Industry Enhancement Authority to create job opportunities for incarcerated individuals in state correctional facilities through partnerships with private industry. The bill requires private companies to employ incarcerated people under specific guidelines, including setting fair wages (with deductions allowed for room/board, victim compensation, and family support), while explicitly prohibiting displacement of civilian jobs or privatization of prisons. It mandates that private sector prison industry programs must operate within the state's "open market" and cannot create competitive advantages for participating businesses. The law aims to develop work skills for post-release employment and strengthen family ties through structured compensation mechanisms.

HB 377 adds tianeptine - a medication sometimes misused as an opioid substitute - to Pennsylvania's list of prohibited substances under the Controlled Substance Act. It makes it illegal for unregistered individuals or unlicensed practitioners to manufacture, deliver, or possess tianeptine with intent to distribute. Violators face felony charges punishable by up to five years in prison, a $15,000 fine, or both. The bill directly affects healthcare providers, pharmacies, and anyone handling tianeptine without proper authorization under state drug laws. This amendment updates existing penalties to address emerging misuse of tianeptine.